Ultrasound Conductivity Gels Market

Ultrasound Conductivity Gels Market: Diagnostic Centers to Give a Cut-throat Competition to Hospitals and Clinics with Growing Technological Advancements: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)

  • 2018-05-03
  • REP-GB-6635
  • 241 pages
  • PDF PPT EXCEL
 Ultrasound Conductivity Gels Market

An Incisive, In-depth Analysis on the Ultrasound Conductivity Gels Market

This study offers a comprehensive, 360 degree analysis on the Ultrasound Conductivity Gels market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Ultrasound Conductivity Gels market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

The use of ultrasound conductivity gels is incessantly across the globe with government support and healthcare expenditure increasing. Government try to minimize the infant and maternal mortality rate employing different schemes and moreover, high population growth and flourishing economy are key dynamics bolstering growth of ultrasound procedures which increase the demand for ultrasound conductivity gels in the global market. The government is employing different schemes for reduction in maternal and infant mortality rate. For instance, Central schemes in India such as the Janani Suraksha Yojna has been launch by government of India so that the women in rural areas can take advantage of professional medical care during prenatal period and have deliveries in hospitals and primary health care centers rather than at home.

Moreover, the increase in the deployment of diagnostic ultrasound procedures has been due in part to technological advances, which have improved the quality of ultrasound images and physicians' aptitude to engage them to diagnose medical conditions. Technological advancements have also resulted in the development of ultrasound devices which are lesser and more portable. The better portability of ultrasound equipment has made it easier for beneficiaries to receive ultrasound exams in skilled nursing facilities (SNF) which further surges the demand for ultrasound procedures and gels.

Clinics are expected to dominate the market in terms of use of ultrasound conductivity gels over the course of the forecast period

The use of ultrasound conductivity gels is comparatively high in clinics as compared to any other healthcare unit as the patients coming for these procedures and the number of procedures taking place is comparatively high here. Ultrasound scanning is considered as an important technology used in emergency wards, intensive care units, operating room and in prenatal conditions to deliver correct patient care. The increasing awareness in early diagnosis and treatment of disease and increase in the number of clinics and diagnostic centers will further increases the demand for ultrasound procedures and boost the need for ultrasound gels globally. The demand for ultrasound gels is also relatively high in middle-income or developing countries as the prevalence of hospitals in these areas is less as compared to that of clinics. Clinics also do not use any substitute and stuck to the status quo in terms of experimenting with ultrasound conductivity gels.

Hospitals and diagnostics centers are gearing up in the adoption of this procedure as well as these ultrasound conductivity gels

Hospitals are expected to foresee comparatively extensive growth owing to the burgeoning demand for ultrasound procedures and also due to developing infrastructure across the globe. Ultrasound conductive gels are used in ultrasound procedures for diagnosis and therapeutic treatment. The gel is applied at the beginning of ultrasound scan. It is also utilized with fetal Doppler to hear heartbeat of an unborn child. Currently, ultrasound technology is generally used in many hospitals and healthcare other facilities.

Additionally, the surge in the employment of ultrasound scanning in rural and remote areas due to its portability, availability, low cost and durability will increase the demand of ultrasound conductivity gels in low and middle cost income countries. As ultrasound is most effective in limited healthcare resources, in past few decades, the ultrasound is gaining traction as a valuable imaging technology and helps in driving the diagnostic ability of hospitals in rural, resource limited countries.

AN outlook of the global ultrasound conductivity gel market with reference to the healthcare industry

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, block chain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

  • Current expenditure on health, % of gross domestic product

  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

  • Annual growth rate of current expenditure on health, per capita, in real terms

  • Out-of-pocket expenditure, % of current expenditure on health

  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

  • Physicians, Density per 1000 population (head counts)

  • Nurses, Density per 1000 population (head counts)

  • Total hospital beds, per 1000 population

  • Curative (acute) care beds, per 1000 population

  • Medical technology, Magnetic Resonance Imaging units, total, per million population

  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Standard Report Structure

  • Executive Summary

  • Market Definition

  • Macro-economic analysis

  • Parent Market Analysis

  • Market Overview

  • Forecast Factors

  • Segmental Analysis and Forecast

  • Regional Analysis

  • Competition Analysis

Market Taxonomy

The global ultrasound conductivity gels market has been segmented into:

Product Type

 

End User

 

Region

 

  • Sterile Gels

  • Non Sterile Gels

 

  • Hospitals

  • Clinics

  • Diagnostic Centers

  • Ambulatory Surgical Centers

 

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific excluding China and Japan

  • China

  • Japan

  • Middle East & Africa

 

Ultrasound Conductivity Gels Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology